Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction

American Journal of Clinical Nutrition

Volumn 77, Issue 5, 2003, Pages 1112-1118

  Breum, Leif ^a,c   Rasmussen, Michael H ^a   Hilsted, Jannik ^a   Fernstrom, John D ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c KØGE HOSPITAL   (Denmark)

Author keywords

Insulin; Large neutral amino acids; Obesity; Plasma tryptophan; Serotonin; Very low energy diet; Weight loss

Indexed keywords

INSULIN; PHENYLALANINE; TRYPTOPHAN; TYROSINE; AMINO ACID; SEROTONIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN INFUSION; INSULIN TOLERANCE TEST; MALE; OBESITY; WEIGHT REDUCTION; AREA UNDER THE CURVE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CIRCADIAN RHYTHM; PHYSIOLOGY;

ADULT; AMINO ACIDS; AREA UNDER CURVE; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; INSULIN; MALE; OBESITY; SEROTONIN; TRYPTOPHAN; WEIGHT LOSS;

EID: 0037797304     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.5.1112     Document Type: Article

References (41)

1. Sugrue MF. Neuropharmacology of drugs affecting food intake. Pharmacol Ther 1987;32:145-82.
2. Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 2000;130:1305-14.
3. Sze JY, Victor M, Loer C, Shi Y, Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 2000;403:560-4.
4. Vickers SP, Clifton PG, Dourish CT, Tecott LH. Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology (Berl) 1999;143:309-14.
5. Blundell JE. Serotonin and appetite. Neuropharmacology 1984;23:1537-51.
6. Silverstone T, Goodall E. Serotoninergic mechanisms in human feeding: the pharmacological evidence. Appetite 1986;7(suppl):85-97.
7. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 1972;178:414-6.
8. Pardridge WM, Oldendorf WH. Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta 1975;401:128-36.
9. Fernstrom JD. Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1990;1:508-17.
10. Fernstrom MH, Fernstrom JD. Brain tryptophan concentrations and serotonin synthesis remain responsive to food consumption after the ingestion of sequential meals. Am J Clin Nutr 1995;61:312-9.
11. Caballero B, Finer N, Wurtman RJ. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements. Metabolism 1988;37:672-6.
12. Ashley DV, Fleury MO, Golay A, Maeder E, Leathwood PD. Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr 1985;42:1240-5.
13. Gatti E, Porrini M, Noe D, Crovetti R, Testolin G. Plasma amino acid changes in obese patients on very low-calorie diets. Int J Vitam Nutr Res 1993;63:81-5.
14. Goodwin GM, Cowen PJ, Fairburn CG, Parry-Billings M, Calder PC, Newsholme EA. Plasma concentrations of tryptophan and dieting. Br Med J 1990;300:1499-500.
15. Jeffery RW, Drewnowski A, Epstein LH, et al. Long-term maintenance of weight loss: current status. Health Psychol 2000;19:5-16.
16. Crandall EA, Fernstrom JD. Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes 1983;32:222-30.
17. Rice DE, Flakoll PJ, May MM, Hill JO, Abumrad NN. The opposing effects of insulin and hyperglycemia in modulating amino acid metabolism during a glucose tolerance test in lean and obese subjects. Metabolism 1994;43:211-6.
18. Luzi L, Castellino P, DeFronzo RA. Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol 1996;270:E273-81.
19. Glass AR, Bongiovanni R, Smith CE, Boehm TM. Normal valine disposal in obese subjects with impaired glucose disposal: evidence for selective insulin resistance. Metabolism 1981;30:578-82.
20. Caballero B, Wurtman RJ. Differential effects of insulin resistance on leucine and glucose kinetics in obesity. Metabolism 1991;40:51-8.
21. Pijl H, Potter van Loon BJ, Toornvliet AC, et al. Insulin-induced decline of plasma amino acid concentrations in obese subjects with and without non-insulin-dependent diabetes. Metabolism 1994;43:640-6.
22. Rasmussen MH, Hvidberg A, Juul A, et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80:1407-15.
23. Hey H, Petersen HD, Andersen T, Quaade F. Formula diet plus free additional food choice up to 103 kcal (4.2 MJ) compared with an isoenergetic conventional diet in the treatment of obesity. Clin Nutr 1986;6:195-9.
24. Han TS, Lean MEJ. Anthropometric indices of obesity and regional distribution of fat depots. In: Bjorntorp P, ed. International textbook of obesity. Chichester, United Kingdom: John Wiley, 2001:51-65.
25. Denckla WD, Dewey HK. Determination of tryptophan in plasma, liver and urine. J Lab Clin Med 1967;69:160-9.
26. Lehmann J. Light - A source of error in the fluorometric determination of tryptophan. Scand J Clin Lab Invest 1971;28:49-55.
27. Bloxam DL, Warren WH. Error in the determination of tryptophan by the method of Denckla and Dewey. A revised procedure. Anal Biochem 1974;60:621-5.
28. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993;39:578-82.
29. Heitmann BL. Body fat in the adult Danish population aged 35-65 years: an epidemiological study. Int J Obes 1991;15:535-45.
30. Fernstrom JD, Wurtman RJ, Hammarstrom Wiklund B, Rand WM, Munro HN, Davidson CS. Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: effect of dietary protein intake. Am J Clin Nutr 1979;32:1912-22.
31. Eriksson T, Voog L, Walinder J, Eriksson TE. Diurnal rhythm in absolute and relative concentrations of large neutral amino acids in human plasma. J Psychiatr Res 1989;23:241-9.
32. Wurtman RJ, Rose CM, Chou C, Larin FF. Daily rhythms in the concentrations of various amino acids in human plasma. N Engl J Med 1968;279:171-5.
33. Milsom JP, Morgan MY, Sherlock S. Factors affecting plasma amino acid concentrations in control subjects. Metabolism 1979;28:313-9.
34. Heraief E, Burckhardt P, Mauron C, Wurtman JJ, Wurtman RJ. The treatment of obesity by carbohydrate deprivation suppresses plasma tryptophan and its ratio to other large neutral amino acids. J Neural Transm 1983;57:187-95.
35. Pijl H, Koppeschaar HPF, Cohen AF, et al. Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans. Int J Obes Relat Metab Disord 1993;17:513-20.
36. Breum L, Moller SE, Andersen T, Astrup A. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss. Int J Obes Relat Metab Disord 1996;20:147-53.
37. Fernstrom JD, Wurtman RJ, Hammarstrom Wiklund B, Rand WM, Munro HN, Davidson CS. Diurnal variations in plasma neutral amino acid concentrations among patients with cirrhosis: effect of dietary protein. Am J Clin Nutr 1979;32:1923-33.
38. Salter M, Pogson CI. The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes. Biochem J 1985;229:499-504.
39. Fukagawa NK, Minaker KL, Young VR, Rowe JW. Insulin dose-dependent reduction in plasma amino acids in man. Am J Physiol 1986;250:E13-7.
40. Wolfe RR. Effects of insulin on muscle tissue. Curr Opin Clin Nutr Metab Care 2000;3:67-71.
41. Curzon G. Serotonin and appetite. Ann N Y Acad Sci 1990;600:521-30.